品牌现货直购
供应商:我要出现这里




查看所有供应商和价格请点击:

494-38-2生产厂家

494-38-2价格

494-38-2

494-38-2结构式
494-38-2结构式
  • 常用中文名:吖啶橙
  • 常用英文名:N3,N3,N6,N6-Tetramethylacridine-3,6-diamine
  • CAS号:494-38-2
  • 分子式:C17H19N3
  • 分子量:265.353
  • 相关类别: 研究领域 其他
  • 发布时间:2018-06-26 19:49:05
  • 更新时间:2024-01-05 16:21:17
  • 吖啶橙基是一种细胞渗透性荧光染料,可将生物体(细菌、寄生虫、病毒等)染色为亮橙色,并在适当条件下使用(pH=3.5,Ex=460 nm),将人类细胞区分为绿色,以便通过荧光显微镜进行检测。吖啶橙基与dsDNA(Ex=488,Em=520-524)结合时发出绿色荧光,与ssDNA(Ex=457,Em=630-644)或ssRNA(Ex=457,Em=630-444)结合时发红色荧光,也可用于细胞周期分析[1][2][3]。

化源商城直购

中文名 吖啶橙
英文名 acridine orange
中文别名 3,6-2(二甲基胺)ㄚ啶
溶剂橙15
英文别名 3,6-Acridinediamine, N,N,N,N-tetramethyl-
N,N,N',N'-Tetramethyl-3,6-acridinediamine
3,6-Bis(dimethylamino)acridine Solvent Orange 15
Acridine Orange base
N,N,N',N'-Tetramethylacridine-3,6-diamine
N3,N3,N6,N6-Tetramethylacridine-3,6-diamine
euchrysine
ACRIDINE ORANGE
描述 吖啶橙基是一种细胞渗透性荧光染料,可将生物体(细菌、寄生虫、病毒等)染色为亮橙色,并在适当条件下使用(pH=3.5,Ex=460 nm),将人类细胞区分为绿色,以便通过荧光显微镜进行检测。吖啶橙基与dsDNA(Ex=488,Em=520-524)结合时发出绿色荧光,与ssDNA(Ex=457,Em=630-644)或ssRNA(Ex=457,Em=630-444)结合时发红色荧光,也可用于细胞周期分析[1][2][3]。
相关类别
体外研究 指南(以下是我们推荐的方案。该方案仅提供指南,应根据您的具体需要进行修改)。1.未固定细胞的DNA和RNA的差异染色[1]:(1)使用发射滤光片和分色镜,在488nm处设置激发流式细胞仪,区分绿色荧光(在515-545nm处测量)和红色发光(最好在640或650nm以上测量)。(2) 将0.2-mL等分的原始细胞悬浮液转移到小玻璃或塑料管中(例如,2-mL或5-mL体积)。在冰上冷却。(3) 轻轻加入0.4 mL冰冷电池渗透溶液。等待15秒,使电池保持在冰上。(4) 轻轻加入1.2 mL冰镇吖啶橙染色液。在黑暗中将电池放在冰上。(5) 添加吖啶橙碱性染色液后2至10分钟内,在流式细胞仪中测量并记录细胞荧光。2.固定细胞的差异染色[1]:(1a)对于悬浮培养或血液样本中的细胞:用冰凉PBS冲洗细胞一次,然后在∼106个细胞/mL。(1b)对于附着在组织培养板上的细胞:用胰酶消化法从烧瓶或培养板中收集细胞,将胰酶消化细胞与悬浮在培养基中的细胞(主要是分离的有丝分裂细胞和死细胞)混合,并用含有血清的培养基冲洗一次,使胰酶失活。将电池悬挂在冰冷的PBS中∼106个细胞/mL。(1c)对于从实体肿瘤中分离出来的细胞:冲洗不含任何用于细胞分离的酶的细胞,并将其悬浮在冰冷的PBS中∼106个细胞/mL。(2) 用巴斯德移液管将1mL细胞悬液转移到含有10mL冰凉70%乙醇的15mL锥形玻璃管中。固定单元格≥冰上2小时。(3) 离心管在300×g,4℃下5分钟。去除所有乙醇,用冰凉PBS冲洗细胞一次,并以<2×106个细胞/mL的密度悬浮在冰凉的PBS中。(4) 提取0.2 mL细胞悬液(≤ 2×105个细胞),然后转移到一个小管中(例如,2或5 mL体积)。在冰上冷却。(5) 添加0.4 mL冰凉渗透溶液。等待15秒,使电池保持在冰上。(6) 添加1.2 mL冰镇吖啶橙基染色液。将电池放在冰上。(7) 添加吖啶橙碱性染色液后2至10分钟内,在流式细胞仪中测量并记录细胞荧光。
参考文献

[1]. Darzynkiewicz Z, et al. Differential staining of DNA and RNA. Curr Protoc Cytom. 2004 Nov;Chapter 7:Unit 7.3.

[2]. Mirrett S. Acridine orange stain. Infect Control. 1982 May-Jun;3(3):250-2.

[3]. Yektaeian N, et al. Lipophilic tracer Dil and fluorescence labeling of acridine orange used for Leishmania major tracing in the fibroblast cells. Heliyon. 2019 Dec 18;5(12):e03073.

密度 1.2±0.1 g/cm3
沸点 468.6±25.0 °C at 760 mmHg
熔点 165ºC (dec.)(lit.)
分子式 C17H19N3
分子量 265.353
闪点 237.2±23.2 °C
精确质量 265.157898
PSA 19.37000
LogP 4.65
外观性状 棕色粉末
蒸汽压 0.0±1.2 mmHg at 25°C
折射率 1.710
储存条件 库房通风低温干燥,与食品原料分开存放

Section1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE
Product identifiers
Product name: Acridine Orange base
CAS-No.: 494-38-2
Relevant identified uses of the substance or mixture and uses advised against
Identified uses: Laboratory chemicals, Manufacture of substances



Section2. HAZARDS IDENTIFICATION
Classification of the substance or mixture
Not a hazardous substance or mixture according to Regulation (EC) No. 1272/2008.
This substance is not classified as dangerous according to Directive 67/548/EEC.
Label elements
The product does not need to be labelled in accordance with EC directives or respective national laws.
Other hazards - none

Section3. COMPOSITION/INFORMATION ON INGREDIENTS
Substances
Synonyms: Solvent Orange 15
3,6-Bis(dimethylamino)acridine
Formula: C17H19N3
Molecular Weight: 265,35 g/mol

Section4. FIRST AID MEASURES
Description of first aid measures
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration.
In case of skin contact
Wash off with soap and plenty of water.
In case of eye contact
Flush eyes with water as a precaution.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water.
Most important symptoms and effects, both acute and delayed
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.
Indication of any immediate medical attention and special treatment needed
no data available

Section5. FIREFIGHTING MEASURES
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, nitrogen oxides (NOx)
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

Section6. ACCIDENTAL RELEASE MEASURES
Personal precautions, protective equipment and emergency procedures
Avoid dust formation. Avoid breathing vapors, mist or gas.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Sweep up and shovel. Keep in suitable, closed containers for disposal.
Reference to other sections
For disposal see section 13.

Section7. HANDLING AND STORAGE
Precautions for safe handling
Provide appropriate exhaust ventilation at places where dust is formed.Normal measures for preventive fire
protection.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Specific end uses
no data available

Section8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
General industrial hygiene practice.
Personal protective equipment
Eye/face protection
Use equipment for eye protection tested and approved under appropriate government standards
such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
Choose body protection in relation to its type, to the concentration and amount of dangerous
substances, and to the specific work-place., The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
Respiratory protection is not required. Where protection from nuisance levels of dusts are desired,
use type N95 (US) or type P1 (EN 143) dust masks. Use respirators and components tested and
approved under appropriate government standards such as NIOSH (US) or CEN (EU).

Section9. PHYSICAL AND CHEMICAL PROPERTIES
Information on basic physical and chemical properties
a) AppearanceForm: solid
b) Odourno data available
c) Odour Thresholdno data available
d) pHno data available
e) Melting point/freezingMelting point/range: 165 °C - dec.
point
f) Initial boiling point and no data available
boiling range
g) Flash pointno data available
h) Evaporation rateno data available
i) Flammability (solid, gas) no data available
j) Upper/lowerno data available
flammability or
explosive limits
k) Vapour pressureno data available
l) Vapour densityno data available
m) Relative densityno data available
n) Water solubilityno data available
o) Partition coefficient: n- no data available
octanol/water
p) Autoignitionno data available
temperature
q) Decompositionno data available
temperature
r) Viscosityno data available
s) Explosive propertiesno data available
t) Oxidizing propertiesno data available
Other safety information
no data available

Section10. STABILITY AND REACTIVITY
Reactivity
no data available
Chemical stability
no data available
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
Other decomposition products - no data available

Section11. TOXICOLOGICAL INFORMATION
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitization
no data available
Germ cell mutagenicity
Laboratory experiments have shown mutagenic effects.
Carcinogenicity
This product is or contains a component that is not classifiable as to its carcinogenicity based on its IARC,
ACGIH, NTP, or EPA classification.
IARC:No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Potential health effects
InhalationMay be harmful if inhaled. May cause respiratory tract irritation.
Ingestion
May be harmful if swallowed.
SkinMay be harmful if absorbed through skin. May cause skin irritation.
Eyes
May cause eye irritation.
Signs and Symptoms of Exposure
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.
Additional Information
RTECS: AR7600000

Section12. ECOLOGICAL INFORMATION
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
no data available
Other adverse effects
no data available

Section13. DISPOSAL CONSIDERATIONS
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company.
Contaminated packaging
Dispose of as unused product.

Section14. TRANSPORT INFORMATION
UN number
ADR/RID: -IMDG: -IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA:Not dangerous goods
Transport hazard class(es)
ADR/RID: -IMDG: -IATA: -
Packaging group
ADR/RID: -IMDG: -IATA: -
Environmental hazards
ADR/RID: noIMDG Marine pollutant: noIATA: no
Special precautions for user
no data available



SECTION 15 - REGULATORY INFORMATION
N/A


SECTION 16 - ADDITIONAL INFORMATION
N/A

CHEMICAL IDENTIFICATION

RTECS NUMBER :
AR7600000
CHEMICAL NAME :
Acridine, 3,6-bis(dimethylamino)-
CAS REGISTRY NUMBER :
494-38-2
BEILSTEIN REFERENCE NO. :
0020916
LAST UPDATED :
199612
DATA ITEMS CITED :
49
MOLECULAR FORMULA :
C17-H19-N3
MOLECULAR WEIGHT :
265.39
WISWESSER LINE NOTATION :
T C666 BNJ EN1&1 MN1&1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
250 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
6630 mg/kg
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Liver - tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
657 mg/kg/63W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Blood - lymphoma, including Hodgkin's disease Tumorigenic - tumors at site of application
TYPE OF TEST :
Sex chromosome loss and nondisjunction
TYPE OF TEST :
Specific locus test
TYPE OF TEST :
Specific locus test
TYPE OF TEST :
Sperm Morphology
TYPE OF TEST :
Micronucleus test
TYPE OF TEST :
Specific locus test
TYPE OF TEST :
DNA inhibition
TYPE OF TEST :
Cytogenetic analysis

MUTATION DATA

TEST SYSTEM :
Bird - chicken
DOSE/DURATION :
1695 ug/kg
REFERENCE :
47JMAE "Cytogenetic Assays of Environmental Mutagens," Hsu, T.C., ed., Totowa, NJ, Allanheld, Osmun & Co., 1982 Volume(issue)/page/year: -,137,1982 *** REVIEWS *** IARC Cancer Review:Animal Inadequate Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 16,145,1978 IARC Cancer Review:Human No Adequate Data IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 16,145,1978 IARC Cancer Review:Group 3 IMSUDL IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- Volume(issue)/page/year: 7,56,1987

危害码 (欧洲) Xn
安全声明 (欧洲) 22-24/25
WGK德国 3
RTECS号 AR7600000